| cytochrome P450, family 2, subfamily C, polypeptide 9 |
4-NONYLPHENOL |
CYP450-2C9 Inhibition |
35% |
NoneNone |
NoneNone |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
HALOPROGIN |
CYP450-2C9 Inhibition |
35% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
HALOPROGIN |
CYP450-2C9 Inhibition |
35% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
ROXARSONE |
CYP450-2C19 Inhibition |
35% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase (YT blood group) |
ERGOCALCIFEROL |
Acetylcholinesterase |
35% |
NoneNone |
NoneNone |
View
|
| collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
ERGOCALCIFEROL |
Acetylcholinesterase |
35% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase |
ERGOCALCIFEROL |
Acetylcholinesterase |
35% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 5B |
BUFLOMEDIL |
Serotonin 5-HT4 |
35% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 4 |
BUFLOMEDIL |
Serotonin 5-HT4 |
35% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Serotonin 5-HT1A |
35% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 5 |
DIPHENIDOL |
Chemokine CCR5 |
35% |
NoneNone |
NoneNone |
View
|
| Sigma-2 Receptor |
AMITRAZ |
Sigma2 |
35% |
NoneNone |
NoneNone |
View
|
| endothelin receptor type A |
ANDROSTERONE |
Endothelin ETA |
35% |
NoneNone |
NoneNone |
View
|
| interleukin 8 receptor, alpha |
DICHLORVOS |
Chemokine CXCR1(IL-8A) |
35% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3B |
BROMHEXINE |
Phosphodiesterase PDE3 |
35% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3A |
BROMHEXINE |
Phosphodiesterase PDE3 |
35% |
NoneNone |
NoneNone |
View
|
| melanocortin 5 receptor |
KITASAMYCIN |
Melanocortin MC5 |
35% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
CLONIDINE |
Cyclooxygenase COX-2 |
35% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
CLONIDINE |
Cyclooxygenase COX-2 |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
NELFINAVIR |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 1 |
NELFINAVIR |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, pi |
NELFINAVIR |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| AT hook, DNA binding motif, containing 1 (DBSS) |
NELFINAVIR |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, theta |
NELFINAVIR |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 2 |
NELFINAVIR |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
NELFINAVIR |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
NELFINAVIR |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, alpha 2 |
NELFINAVIR |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, alpha 1 |
NELFINAVIR |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
NELFINAVIR |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
NELFINAVIR |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, delta |
NELFINAVIR |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
NELFINAVIR |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 2 |
PYRILAMINE |
Muscarinic M2 |
35% |
NoneNone |
NoneNone |
View
|
| opioid receptor, sigma 1 |
SPARTEINE |
Sigma1 |
35% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 4 polypeptide |
TERCONAZOLE |
ATPase, Na+/K+ |
35% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 3 polypeptide |
TERCONAZOLE |
ATPase, Na+/K+ |
35% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 2 polypeptide |
TERCONAZOLE |
ATPase, Na+/K+ |
35% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 1 polypeptide |
TERCONAZOLE |
ATPase, Na+/K+ |
35% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 1 polypeptide |
TERCONAZOLE |
ATPase, Na+/K+ |
35% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 3 polypeptide |
TERCONAZOLE |
ATPase, Na+/K+ |
35% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 2 polypeptide |
TERCONAZOLE |
ATPase, Na+/K+ |
35% |
NoneNone |
NoneNone |
View
|
| ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
TERCONAZOLE |
ATPase, Na+/K+ |
35% |
NoneNone |
NoneNone |
View
|
| angiotensin 1 converting enzyme 1 |
NELFINAVIR |
Protease, Angiotensin Converting Enzyme |
35% |
NoneNone |
NoneNone |
View
|
| angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
NELFINAVIR |
Protease, Angiotensin Converting Enzyme |
35% |
NoneNone |
NoneNone |
View
|
| opioid receptor, kappa 1 |
PAROXETINE |
Opiate kappa |
35% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
VX-745 |
Leukotriene B4 |
35% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
VX-745 |
Leukotriene B4 |
35% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
VX-745 |
Leukotriene B4 |
35% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
VX-745 |
Leukotriene B4 |
35% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, alpha |
17-METHYLTESTOSTERONE |
Sodium Channel, Site 2 |
35% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
MC 258717 |
Sodium Channel, Site 2 |
34% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, alpha |
MC 258717 |
Sodium Channel, Site 2 |
34% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, alpha |
MC 258717 |
Sodium Channel, Site 2 |
34% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, beta |
MC 258717 |
Sodium Channel, Site 2 |
34% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, alpha 2 |
MC 258717 |
Sodium Channel, Site 2 |
34% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, beta |
MC 258717 |
Sodium Channel, Site 2 |
34% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, alpha |
MC 258717 |
Sodium Channel, Site 2 |
34% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
METFORMIN |
CYP450-1A2 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| platelet-derived growth factor receptor, beta polypeptide |
CYTARABINE |
Platelet-Derived Growth Factor (PDGF) |
34% |
NoneNone |
NoneNone |
View
|
| Sigma-2 Receptor |
TETRACAINE |
Sigma2 |
34% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 5 |
ATORVASTATIN |
Muscarinic M5 |
34% |
NoneNone |
NoneNone |
View
|
| melanocortin 5 receptor |
CLOZAPINE |
Melanocortin MC5 |
34% |
NoneNone |
NoneNone |
View
|
| arginine vasopressin receptor 1A |
FLUOCINOLONE ACETONIDE |
Vasopressin V1A |
34% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
DESOXIMETASONE |
CYP450-2D6 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| glycine receptor, alpha 3 |
TIMOLOL |
Glycine, Strychnine-Sensitive |
34% |
NoneNone |
NoneNone |
View
|
| glycine receptor, alpha 1 subunit |
TIMOLOL |
Glycine, Strychnine-Sensitive |
34% |
NoneNone |
NoneNone |
View
|
| glycine receptor, beta subunit |
TIMOLOL |
Glycine, Strychnine-Sensitive |
34% |
NoneNone |
NoneNone |
View
|
| glycine receptor, alpha 2 subunit |
TIMOLOL |
Glycine, Strychnine-Sensitive |
34% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
5-FLUORO-2'-DEOXYURIDINE |
CYP450-1A2 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
FLUOXETINE |
Adrenergic alpha1D |
34% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 |
FLUPHENAZINE |
Thromboxane Synthetase |
34% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
FLUPHENAZINE |
Thromboxane Synthetase |
34% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 1 (interstitial collagenase) |
BENZOTHIAZYL DISULFIDE |
Protease, Matrix Metalloprotease-1 (MMP-1) |
34% |
NoneNone |
NoneNone |
View
|
| melanocortin 3 receptor |
FLUPHENAZINE |
Melanocortin MC3 |
34% |
NoneNone |
NoneNone |
View
|
| melanocortin 3 receptor |
FLUPHENAZINE |
Melanocortin MC3 |
34% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
CAPSAICIN |
Cyclooxygenase COX-2 |
34% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
CAPSAICIN |
Cyclooxygenase COX-2 |
34% |
NoneNone |
NoneNone |
View
|
| adenosine A2a receptor |
CAFFEIC ACID PHENETHYL ESTER |
Adenosine A2A |
34% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 |
FLUORESCEIN |
Thromboxane Synthetase |
34% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
FLUORESCEIN |
Thromboxane Synthetase |
34% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
IPRIFLAVONE |
Adenosine A3 |
34% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
MC 288769 |
Adenosine A3 |
34% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
TOLNAFTATE |
Monoamine Oxidase MAOA |
34% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
TOLNAFTATE |
Monoamine Oxidase MAOA |
34% |
NoneNone |
NoneNone |
View
|
| melanocortin 5 receptor |
TOPOTECAN |
Melanocortin MC5 |
34% |
NoneNone |
NoneNone |
View
|
| matrix metallopeptidase 9 |
TOPOTECAN |
Protease, Matrix Metalloprotease-9 (MMP-9) |
34% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
TOPOTECAN |
Protease, Matrix Metalloprotease-9 (MMP-9) |
34% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 5B |
MC 288769 |
Serotonin 5-HT4 |
34% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 4 |
MC 288769 |
Serotonin 5-HT4 |
34% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
FLAVOXATE |
Adrenergic alpha1D |
34% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1B |
SULINDAC SULFIDE |
Serotonin 5-HT1B |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
SULINDAC SULFIDE |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
SULINDAC SULFIDE |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
SULINDAC SULFIDE |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
SULINDAC SULFIDE |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
SULINDAC SULFIDE |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
SULINDAC SULFIDE |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
SULINDAC SULFIDE |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
SULINDAC SULFIDE |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
SULINDAC SULFIDE |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
SULINDAC SULFIDE |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
SULINDAC SULFIDE |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
SULINDAC SULFIDE |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
SULINDAC SULFIDE |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
SULINDAC SULFIDE |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
SULINDAC SULFIDE |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
4-NONYLPHENOL |
Calcium Channel Type L, Dihydropyridine |
34% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
TERBINAFINE |
CYP450-3A4 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
TIBOLONE |
CYP450-3A4 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
TRAZODONE |
CYP450-2D6 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
DOBUTAMINE |
CYP450-2C9 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
DOBUTAMINE |
CYP450-2C9 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
SULFINPYRAZONE |
CYP450-2C19 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
OXYMETAZOLINE |
CYP450-2C19 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
PROBENECID |
CYP450-2C19 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
PUROMYCIN |
CYP450-2C19 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
DOMPERIDONE |
Adenosine A3 |
34% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
CYCLANDELATE |
Adenosine A3 |
34% |
NoneNone |
NoneNone |
View
|
| melanocortin 5 receptor |
BITHIONOL |
Melanocortin MC5 |
34% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 1a |
BUFLOMEDIL |
Adrenergic alpha1A |
34% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
TEICOPLANIN |
Leukotriene C4 Synthetase |
34% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
TEICOPLANIN |
Leukotriene C4 Synthetase |
34% |
NoneNone |
NoneNone |
View
|
| Protein-tyrosine kinase, Fyn |
BITHIONOL |
Protein Tyrosine Kinase, Fyn |
34% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3B |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Phosphodiesterase PDE3 |
34% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3A |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Phosphodiesterase PDE3 |
34% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D4 |
BITHIONOL |
Dopamine D4.2 |
34% |
NoneNone |
NoneNone |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
BITHIONOL |
Potassium Channel [KATP] |
34% |
NoneNone |
NoneNone |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
BITHIONOL |
Potassium Channel [KATP] |
34% |
NoneNone |
NoneNone |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
BITHIONOL |
Potassium Channel [KATP] |
34% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
ALPHA-ERGOCRYPTINE |
Leukotriene C4 Synthetase |
34% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
ALPHA-ERGOCRYPTINE |
Leukotriene C4 Synthetase |
34% |
NoneNone |
NoneNone |
View
|
| histamine receptor H 2 |
METHYLERGONOVINE |
Histamine H2 |
34% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
ETHYLESTRENOL |
Protein Serine/Threonine Kinase, ERK1 |
34% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
ETHYLESTRENOL |
Protein Serine/Threonine Kinase, ERK1 |
34% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 |
STRYCHNINE |
Thromboxane Synthetase |
34% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
STRYCHNINE |
Thromboxane Synthetase |
34% |
NoneNone |
NoneNone |
View
|
| solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 |
DICHLORVOS |
Adenosine Transporter |
34% |
NoneNone |
NoneNone |
View
|
| concentrative Na+ nucleoside cotransporter (DBSS) |
DICHLORVOS |
Adenosine Transporter |
34% |
NoneNone |
NoneNone |
View
|
| solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
DICHLORVOS |
Adenosine Transporter |
34% |
NoneNone |
NoneNone |
View
|
| adenine nucleotide translocase (DBSS) (Non-specific probe) |
DICHLORVOS |
Adenosine Transporter |
34% |
NoneNone |
NoneNone |
View
|
| solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
DICHLORVOS |
Adenosine Transporter |
34% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 1 (interstitial collagenase) |
DACTINOMYCIN |
Protease, Matrix Metalloprotease-1 (MMP-1) |
34% |
NoneNone |
NoneNone |
View
|
| lymphocyte protein tyrosine kinase (mapped) |
AMPHOTERICIN B |
Protein Tyrosine Kinase, Lck |
34% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 |
AMPHOTERICIN B |
Thromboxane Synthetase |
34% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
AMPHOTERICIN B |
Thromboxane Synthetase |
34% |
NoneNone |
NoneNone |
View
|
| Protein-tyrosine kinase, Fyn |
MAPROTILINE |
Protein Tyrosine Kinase, Fyn |
34% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
LISURIDE |
Protein Serine/Threonine Kinase, ERK2 |
34% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
LISURIDE |
Protein Serine/Threonine Kinase, ERK2 |
34% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D4 |
DIHYDROERGOCRISTINE MESYLATE |
Dopamine D4.2 |
34% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
BUSPIRONE |
Adrenergic alpha2C |
34% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
BUSPIRONE |
Adrenergic alpha2C |
34% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, beta 2 |
PYRILAMINE |
Adrenergic beta2 |
34% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
ERGOTAMINE |
CYP450-2D6 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
ETHYLENE GLYCOL |
Protein Serine/Threonine Kinase, ERK1 |
34% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
ETHYLENE GLYCOL |
Protein Serine/Threonine Kinase, ERK1 |
34% |
NoneNone |
NoneNone |
View
|
| Sigma-2 Receptor |
VX-745 |
Sigma2 |
34% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
NELFINAVIR |
Serotonin 5-HT2A |
34% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
QUINAPRIL |
Serotonin 5-HT2B |
34% |
NoneNone |
NoneNone |
View
|
| melanocortin 4 receptor |
SECOBARBITAL |
Melanocortin MC4 |
34% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 4 |
6-METHOXY-2-NAPHTHYLACETIC ACID |
Chemokine CCR4 |
34% |
NoneNone |
NoneNone |
View
|
| Protein-tyrosine kinase, Fyn |
ZOPICLONE |
Protein Tyrosine Kinase, Fyn |
34% |
NoneNone |
NoneNone |
View
|
| opioid receptor, delta 1 |
ROSIGLITAZONE |
Opiate delta |
34% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4A, cAMP specific |
ROSIGLITAZONE |
Phosphodiesterase PDE4 |
34% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4C, cAMP-specific |
ROSIGLITAZONE |
Phosphodiesterase PDE4 |
34% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4D |
ROSIGLITAZONE |
Phosphodiesterase PDE4 |
34% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4B, cAMP specific |
ROSIGLITAZONE |
Phosphodiesterase PDE4 |
34% |
NoneNone |
NoneNone |
View
|
| tachykinin receptor 2 |
PROCHLORPERAZINE |
Tachykinin NK2 |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
R-(+)-PROPRANOLOL |
Calcium Channel Type L, Benzothiazepine |
35% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
R-(+)-PROPRANOLOL |
Calcium Channel Type L, Benzothiazepine |
35% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
R-(+)-PROPRANOLOL |
Calcium Channel Type L, Benzothiazepine |
35% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
R-(+)-PROPRANOLOL |
Calcium Channel Type L, Benzothiazepine |
35% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
R-(+)-PROPRANOLOL |
Calcium Channel Type L, Benzothiazepine |
35% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
R-(+)-PROPRANOLOL |
Calcium Channel Type L, Benzothiazepine |
35% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
R-(+)-PROPRANOLOL |
Calcium Channel Type L, Benzothiazepine |
35% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
R-(+)-PROPRANOLOL |
Calcium Channel Type L, Benzothiazepine |
35% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
R-(+)-PROPRANOLOL |
Calcium Channel Type L, Benzothiazepine |
35% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
R-(+)-PROPRANOLOL |
Calcium Channel Type L, Benzothiazepine |
35% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
R-(+)-PROPRANOLOL |
Calcium Channel Type L, Benzothiazepine |
35% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
R-(+)-PROPRANOLOL |
Calcium Channel Type L, Benzothiazepine |
35% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
ESTRIOL |
CYP450-1A2 Inhibition |
35% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
TRAZODONE |
Dopamine Transporter |
35% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 1 |
MOSAPRIDE |
Muscarinic M1 |
35% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
MOSAPRIDE |
Sodium Channel, Site 2 |
35% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 1 |
MOSAPRIDE |
Sodium Channel, Site 2 |
35% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 2 |
MOSAPRIDE |
Sodium Channel, Site 2 |
35% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, beta |
MOSAPRIDE |
Sodium Channel, Site 2 |
35% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, alpha |
MOSAPRIDE |
Sodium Channel, Site 2 |
35% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IX, alpha |
MOSAPRIDE |
Sodium Channel, Site 2 |
35% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VII, alpha |
MOSAPRIDE |
Sodium Channel, Site 2 |
35% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
BETAMETHASONE PHOSPHATE |
Progesterone |
35% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
BETAMETHASONE PHOSPHATE |
Progesterone |
35% |
NoneNone |
NoneNone |
View
|
| FMS-like tyrosine kinase 1 |
(RS)-AMPA |
Vascular Endothelinal Growth Factor (VEGF) |
35% |
NoneNone |
NoneNone |
View
|
| fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
(RS)-AMPA |
Vascular Endothelinal Growth Factor (VEGF) |
35% |
NoneNone |
NoneNone |
View
|
| matrix metallopeptidase 9 |
NIFEDIPINE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
35% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
NIFEDIPINE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
35% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
CLOFIBRATE |
Cyclooxygenase COX-2 |
35% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
CLOFIBRATE |
Cyclooxygenase COX-2 |
35% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
NIFEDIPINE |
Adrenergic alpha2A |
35% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
DIFLUNISAL |
Cyclooxygenase COX-1 |
35% |
NoneNone |
NoneNone |
View
|